Results of a small study of very ill COVID-19 patients showed promising outcomes for a potential treatment developed through research centered at the University of Alabama at Birmingham.
More than two-thirds of the 53 patients who received the drug remdesivir showed improvement, according to an articlepublished Friday in the New England Journal of Medicine.
For more of the story please go to: al.com
Recent Comments